Dillard's
DDS
649.38
-5.87
-0.90%
Dillard's
US · DDS
#1449 by market cap
Listed 1970
649.38
-5.87
-0.90%
Live - 5344 symbols - heartbeat 272s ago
· 2026-10-07 19:54
After-hours
649.38
0.00%
- Market cap
- 10.14B
- P/E (TTM)i
- 14.88
- P/Bi
- 4.78
- EPSi
- 36.42
- Div yieldi
- 0.18%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on DDS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 9.08, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.41% YoY
Margins
- Gross margin
- 40.32%
- Operating margin
- 10.49%
- Net margin
- 8.69%
Key ratios & quality
- Enterprise valuei
- 9.60B
- Altman Z-Scorei
- 9.08
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.50B | 6.34B | 4.43B | 6.62B | 7.00B | 6.87B | 6.59B | 6.56B |
| Gross profit | 2.21B | 2.11B | 1.36B | 2.88B | 3.01B | 2.84B | 2.67B | 2.65B |
| Selling & admin expenses | 1.72B | 1.72B | 1.23B | 1.56B | 1.70B | 1.74B | 1.75B | 1.78B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 268.19M | 167.49M | -82.91M | 1.12B | 1.13B | 924.76M | 740.16M | 688.67M |
| Pretax profit | 207.96M | 133.89M | -153.40M | 1.09B | 1.11B | 916.62M | 729.70M | 694.48M |
| Tax | 37.73M | 22.81M | -81.75M | 225.89M | 217.83M | 177.77M | 136.23M | 124.70M |
| Net profit | 170.26M | 111.08M | -71.65M | 862.47M | 891.64M | 738.85M | 593.48M | 570.19M |
| Basic EPS | 6 | 4 | -3 | 42 | 51 | 45 | 37 | 36 |
| Diluted EPS | 6.23 | 4.38 | -3.16 | 41.88 | 50.81 | 44.73 | 36.82 | 36.42 |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 1.55B | 1.54B | 1.49B | 1.99B | 1.59B | 1.53B |
| Gross profit | 689.28M | 576.70M | 659.33M | 721.17M | 718.25M | 621.09M |
| Selling & admin expenses | 426.29M | 438.72M | 444.76M | 468.69M | 447.87M | 447.46M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 218.51M | 93.32M | 170.19M | 206.65M | 227.11M | 129.27M |
| Pretax profit | 213.70M | 94.59M | 168.81M | 217.39M | 327.04M | 127.14M |
| Tax | 49.88M | 21.75M | 39.00M | 14.07M | 76.78M | 29.76M |
| Net profit | 163.82M | 72.84M | 129.81M | 203.73M | 250.55M | 97.69M |
| Basic EPS | 10 | 5 | 8 | 13 | 16 | 6 |
| Diluted EPS | 10.39 | 4.66 | 8.31 | 13.05 | 16.04 | 6.25 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.77B | 1.85B | 1.66B | 1.91B | 2.07B | 2.21B | 2.37B | 2.39B |
| Cash & ST investments | 123.51M | 277.08M | 360.34M | 716.76M | 799.24M | 956.32M | 1.04B | 1.07B |
| Inventory | 1.53B | 1.47B | 1.09B | 1.08B | 1.12B | 1.09B | 1.17B | 1.20B |
| Total assets | 3.43B | 3.43B | 3.09B | 3.25B | 3.33B | 3.45B | 3.53B | 3.51B |
| Total current liabilities | 933.54M | 930.82M | 772.88M | 966.19M | 858.96M | 827.76M | 834.91M | 902.08M |
| Short-term debt | 1.21M | 15.87M | 14.51M | 56.51M | 9.70M | 11.25M | 11.41M | 105.55M |
| Long-term debt | 565.57M | 565.71M | 565.85M | 521.25M | 521.35M | 521.46M | 521.57M | 425.67M |
| Total liabilities | 1,752,988,000.00 | 1,806,998,000.00 | 1,651,507,000.00 | 1,794,339,000.00 | 1,730,512,000.00 | 1,751,838,000.00 | 1,734,894,000.00 | 1,726,053,000.00 |
| Total equity | 1.68B | 1.62B | 1.44B | 1.45B | 1.60B | 1.70B | 1.80B | 1.78B |
| Retained earnings | 4.46B | 4.56B | 4.47B | 5.03B | 5.65B | 6.05B | 6.23B | 6.31B |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 2.77B | 2.57B | 3.17B | 2.39B | 3.05B | 2.68B |
| Cash & ST investments | 1.16B | 1.21B | 1.33B | 1.07B | 1.42B | 1.26B |
| Inventory | 1.47B | 1.22B | 1.72B | 1.20B | 1.51B | 1.28B |
| Total assets | 3.91B | 3.68B | 4.30B | 3.51B | 4.14B | 3.75B |
| Total current liabilities | 1.15B | 958.71M | 1.45B | 902.08M | 1.29B | 883.79M |
| Short-term debt | 10.81M | 106.47M | 106.04M | 105.55M | 105.36M | 89.10M |
| Long-term debt | 521.59M | 425.62M | 425.65M | 425.67M | 425.70M | 345.73M |
| Total liabilities | 2,049,139,000.00 | 1,765,361,000.00 | 2,253,019,000.00 | 1,726,053,000.00 | 2,112,202,000.00 | 1,629,195,000.00 |
| Total equity | 1.86B | 1.92B | 2.05B | 1.78B | 2.03B | 2.12B |
| Retained earnings | 6.39B | 6.46B | 6.58B | 6.31B | 6.56B | 6.65B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 367.29M | 365.07M | 252.95M | 1.28B | 948.39M | 883.59M | 714.13M | 717.01M |
| Depreciation & amortization | 225.85M | 224.31M | 216.32M | 201.44M | 190.03M | 181.18M | 179.52M | 180.86M |
| Free cash flow | 230.22M | 261.69M | 192.49M | 1.18B | 828.29M | 750.65M | 609.58M | 623.63M |
| Dividends paid | -11.11M | -11.52M | -13.98M | -305.24M | -271.31M | -338.63M | -413.80M | -484.88M |
| Stock buybacks / issuance | -129.88M | -130.93M | -102.88M | -544.87M | -452.85M | -281.41M | -121.03M | -107.76M |
| Ending cash balance | 123.51M | 277.08M | 360.34M | 716.76M | 660.33M | 808.29M | 717.85M | 861.46M |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 232.63M | 86.76M | 186.46M | 211.15M | 363.98M | -37.18M |
| Depreciation & amortization | 44.85M | 45.04M | 44.76M | 46.21M | 43.68M | 44.76M |
| Free cash flow | 215.78M | 60.09M | 156.15M | 191.61M | 346.77M | -59.45M |
| Dividends paid | -3.98M | -3.92M | -3.90M | -473.07M | -4.68M | -4.69M |
| Stock buybacks / issuance | -98.00M | -9.76M | 0 | 0 | 0 | 0 |
| Ending cash balance | 900.50M | 1.01B | 1.15B | 861.46M | 1.16B | 763.08M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 10.06 | 6.73 | -4.68 | 59.64 | 58.47 | 44.84 | 33.98 | 31.90 |
| ROA %i | 4.79 | 3.24 | -2.20 | 27.22 | 27.12 | 21.80 | 17.01 | 16.21 |
| ROIC %i | 9.10 | 6.66 | -1.67 | 43.58 | 43.48 | 33.30 | 25.25 | 24.11 |
| 5-year avg ROE %i | 12.66 | 10.69 | 6.93 | 16.93 | 26.04 | 33.00 | 38.45 | 45.76 |
| EBIT margin %i | 4.02 | 2.86 | -2.34 | 17.11 | 16.48 | 13.92 | 11.68 | 11.21 |
| FCF / sales %i | 3.54 | 4.13 | 4.34 | 17.75 | 11.84 | 10.92 | 9.25 | 9.50 |
| Current ratioi | 1.90 | 1.99 | 2.15 | 1.98 | 2.41 | 2.67 | 2.84 | 2.65 |
| Quick ratioi | 0.19 | 0.35 | 0.67 | 0.78 | 1.00 | 1.23 | 1.32 | 1.23 |
| Debt / assetsi | 16.57 | 17.93 | 19.85 | 18.76 | 16.68 | 16.37 | 15.73 | 15.91 |
| LT debt / equityi | 33.80 | 36.91 | 41.58 | 38.05 | 34.12 | 32.60 | 30.28 | 25.41 |
| Interest coveragei | 4.88 | 3.82 | -2.09 | 25.22 | 26.59 | 23.55 | 19.30 | 17.93 |
| Revenue CAGR (3Y) %i | -1.26 | -0.39 | -11.62 | 0.62 | 3.32 | 15.75 | -0.17 | -2.11 |
| Net income CAGR (3Y) %i | -14.18 | -13.09 | -- | 71.74 | 100.22 | -- | -11.72 | -13.85 |
| FCF CAGR (3Y) %i | -6.81 | -13.72 | 10.20 | 72.20 | 46.82 | 57.40 | -19.66 | -9.03 |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 30.93 | 29.76 | 28.98 | 31.90 | 33.83 | 33.75 |
| ROA %i | 14.72 | 15.67 | 13.78 | 16.21 | 16.33 | 18.34 |
| ROIC %i | 22.09 | 21.53 | 21.21 | 24.11 | 24.78 | 25.46 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.44 | 11.31 | 11.34 | 11.21 | 11.27 | 11.82 |
| FCF / sales %i | 9.39 | 11.70 | 11.79 | 9.50 | 11.43 | 9.62 |
| Current ratioi | 2.41 | 2.68 | 2.19 | 2.65 | 2.37 | 3.03 |
| Quick ratioi | 1.06 | 1.32 | 0.95 | 1.23 | 1.14 | 1.49 |
| Debt / assetsi | 14.18 | 14.96 | 12.76 | 15.91 | 13.42 | 12.18 |
| LT debt / equityi | 29.23 | 23.17 | 21.64 | 25.41 | 22.22 | 17.34 |
| Interest coveragei | -- | -- | -- | 17.93 | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Retail operations is the largest reported line at 96.56% of revenue, across 3 reported segments.
- The next-largest line, Construction, is a distant second at 3.67% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Retail operations96.56%
Construction3.67%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.